New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools

Neurodegenerative diseases (NDD) have been of great interest to scientists for a long time due to their multifactorial character. Among these pathologies, Alzheimer’s disease (AD) is of special relevance, and despite the existence of approved drugs for its treatment, there is still no efficient phar...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lily Arrué, Alexandra Cigna-Méndez, Tábata Barbosa, Paola Borrego-Muñoz, Silvia Struve-Villalobos, Victoria Oviedo, Claudia Martínez-García, Alexis Sepúlveda-Lara, Natalia Millán, José C. E. Márquez Montesinos, Juana Muñoz, Paula A. Santana, Carlos Peña-Varas, George E. Barreto, Janneth González, David Ramírez
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-09-01
Col·lecció:	Pharmaceutics
Matèries:	Alzheimer’s disease drug design computational polypharmacology bioinformatics pharmacoinformatics multitarget directed ligands
Accés en línia:	https://www.mdpi.com/1999-4923/14/9/1914
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!